We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
2026
Grand Canyon Education
LOPE
$3.88B
$985K ﹤0.01%
12,558
-1,382
-10% -$106K
GER
2027
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$985K ﹤0.01%
15,196
+1,444
+11% +$99.3K
USAC icon
2028
USA Compression Partners
USAC
$3.78B
$983K ﹤0.01%
60,077
-191
-0.3% -$3.15K
JGH icon
2029
Nuveen Global High Income Fund
JGH
$355M
$981K ﹤0.01%
58,144
-48,555
-46% -$815K
TCP
2030
DELISTED
TC Pipelines LP
TCP
$981K ﹤0.01%
17,840
-6,250
-26% -$357K
GNTX icon
2031
Gentex
GNTX
$4.96B
$979K ﹤0.01%
51,616
-81,989
-61% -$1.6M
RRD
2032
DELISTED
RR Donnelley & Sons Co.
RRD
$974K ﹤0.01%
77,673
+14,262
+22% +$175K
J icon
2033
Jacobs Solutions
J
$16.9B
$973K ﹤0.01%
21,632
-688
-3% -$30.6K
VKQ icon
2034
Invesco Municipal Trust
VKQ
$547M
$973K ﹤0.01%
75,813
+4,420
+6% +$56.1K
KLIC icon
2035
Kulicke & Soffa
KLIC
$4.74B
$969K ﹤0.01%
50,949
+29,542
+138% +$622K
MQY icon
2036
BlackRock MuniYield Quality Fund
MQY
$812M
$969K ﹤0.01%
63,150
+2,482
+4% +$38.1K
CRESY
2037
Cresud
CRESY
$766M
$968K ﹤0.01%
55,774
-1,277
-2% -$23.3K
SGOL icon
2038
abrdn Physical Gold Shares ETF
SGOL
$7.25B
$968K ﹤0.01%
80,370
-170
-0.2% -$2.08K
VDC icon
2039
Vanguard Consumer Staples ETF
VDC
$7.98B
$966K ﹤0.01%
6,851
-714
-9% -$102K
JBTM
2040
JBT Marel
JBTM
$6.36B
$965K ﹤0.01%
9,850
+774
+9% +$68.7K
LW icon
2041
Lamb Weston
LW
$7.16B
$961K ﹤0.01%
21,827
-4,356
-17% -$191K
WELL.PRI
2042
DELISTED
Welltower Inc.
WELL.PRI
$961K ﹤0.01%
14,500
CSL icon
2043
Carlisle Companies
CSL
$15.2B
$960K ﹤0.01%
10,061
-4,308
-30% -$435K
KMX icon
2044
CarMax
KMX
$8.24B
$959K ﹤0.01%
15,200
-1,922
-11% -$116K
VBF icon
2045
Invesco Bond Fund
VBF
$169M
$956K ﹤0.01%
48,915
-65,375
-57% -$1.26M
APLE icon
2046
Apple Hospitality REIT
APLE
$3.77B
$955K ﹤0.01%
51,059
+31,910
+167% +$606K
ETJ
2047
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$572M
$955K ﹤0.01%
101,876
+1,346
+1% +$12.5K
RZG icon
2048
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$141M
$946K ﹤0.01%
27,594
-1,779
-6% -$59.8K
BF.A icon
2049
Brown-Forman Class A
BF.A
$13.1B
$945K ﹤0.01%
23,963
+377
+2% +$15.1K
ORA icon
2050
Ormat Technologies
ORA
$6.6B
$942K ﹤0.01%
16,045
+412
+3% +$24.2K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.